Susan Stewart, J.D., has worked for nearly 30 years in biopharmaceutical regulatory affairs, with significant experience devising innovative strategies for novel therapeutics, overseeing regulatory submissions at various stages of product development, and leading interactions with global health authorities. An independent consultant, Ms. Stewart serves as Chief Regulatory Officer for Candel Therapeutics in addition to Chief Regulatory Officer, Regulatory, and Quality for Kaleido Biosciences and Frequency Therapeutics. Prior roles have included Senior Vice President of Regulatory Affairs and Quality at Kaleido Biosciences, Senior Vice President of Regulatory Affairs, Quality, and Compliance at Tokai Pharmaceuticals and Vice President, Regulatory Affairs at Transmolecular. Ms. Stewart also spent 13 years at Genzyme Corporation in regulatory and compliance roles, including serving as Vice President, Regulatory Affairs and began her career with Abbott Laboratories. She is a Fellow of the Regulatory Affairs Professionals Society, a Director of the Board, and holds Regulatory Affairs Certifications for both the United States and Europe. Ms. Stewart received her J.D. from Concord Law School at Purdue University Global and her B.A. from the University of Massachusetts.